INDV
Indivior Pharmaceuticals, Inc.
Stock
$35.71+0.33 (+0.93%)Close Oct 2, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash and short-term investments | $222M | $195M | $320M | $410M | $774M | $1.1B |
| Inventory | $150M | $153M | $167M | $126M | $114M | $95M |
| Current assets | $725M | $652M | $827M | $1.3B | $1.3B | $1.4B |
| Goodwill | — | $2.0M | $2.0M | $5.0M | — | — |
| Total assets | $1.2B | $1.2B | $1.3B | $1.8B | $1.8B | $1.8B |
| Current liabilities | $868M | $914M | $924M | $1.3B | $1.0B | $804M |
| Long-term debt | $487M | $290M | $315M | $237M | $237M | $239M |
| Total liabilities | $1.4B | $1.3B | $1.7B | $1.9B | $1.7B | $1.6B |
| Shareholders' equity | −$208M | −$98M | −$337M | −$184M | −$15M | $121M |
| Shares outstanding | 118.0M | 125.1M | 124.7M | 136.5M | — | — |
| Current ratio | 0.84 | 0.71 | 0.90 | 0.98 | 1.24 | 1.80 |